<DOC>
	<DOCNO>NCT01748955</DOCNO>
	<brief_summary>This study use functional magnetic resonance imaging ( fMRI ) investigate effect two different antidepressant medication ( Paxil CR versus Wellbutrin XL ) reward processing depress patient attempted suicide currently experience suicidal thought .</brief_summary>
	<brief_title>Paroxetine/Bupropion Depression With Suicide Attempt Thoughts : fMRI Study</brief_title>
	<detailed_description>Major depressive disorder ( MDD ) common serious psychiatric illness . It among lead cause disability psychiatric disorder often associate suicide . The treatment MDD antidepressant medication remain largely trial error . Little empirical evidence exists guide treatment MDD suicide risk major factor . The study use functional magnetic resonance imaging ( fMRI ) compare effect paroxetine , SSRI , versus bupropion , non-SSRI , brain activity depress patient past suicide attempt and/or current suicidal thought . Participants randomly assign either paroxetine bupropion treatment 8 week , fMRI scan involve reward processing task baseline Week 8 . Weekly study visit include interview psychologist , self-report scale , medication monitoring . All participant offer 4 additional month open clinical treatment . If original medication assignment prove ineffective , participant option switch another medication . After complete study , participant refer ongoing treatment .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Suicidal Ideation</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>1 . Patient suffer episode major depressive disorder ( MDD ) 2 . Age range 1865 year 3 . History past suicide attempt score &gt; 2 HDRS item # 3 ( suicide ) inperson screen interview . Patients suicidal plan intent enrol inpatient independent inpatient treatment team agree plan enroll patient . 4 . Patients 60 year age old must score least 25 MMSE screening . 5 . Patients 60 year age old must normal ECG within past year . 1 . Bipolar disorder ; current psychotic symptom ; bulimia anorexia current within past year , current purge least twice week three month ; person already take SSRIs bupropion indication ( anxiety disorder ) . 2 . Primary disorder anxiety disorder Panic disorder/GAD/OCD/ Social anxiety disorder , secondary depression . 3 . Drug alcohol dependence within past six month ; person current drug alcohol abuse may enrol assess less importance major depressive episode . 4 . Blood pressure read â‰¥ 140/90 5 . Active and/or unstable medical problem include significant risk seizures 6 . Antipsychotic medication require 7 . Patients become hypomanic manic antidepressant 8 . Contraindication use SSRI bupropion , currently use Zyban . Anorexia nervosa remission least one year exclusion . 9 . Failure respond adequate trial 3 SSRIs paroxetine bupropion last 2 year ( failure respond therapeutic trial define : least 2/3 maximal PDR dose least 6 week ) . 10 . Lacks capacity consent 11 . Pregnancy , lactation , plan conceive course study participation . 12 . Patients currently effective treatment , require adjunctive antipsychotic mood stabilize medication , unlikely respond single agent treatment depression exclude . 13 . Patients ferrous metal implant body , history claustrophobia precludes MRI , exclude . 14 . Patients assess unlikely tolerate maximum 2week delay start treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Reward</keyword>
	<keyword>BOLD signal</keyword>
	<keyword>Suicide</keyword>
</DOC>